Literature DB >> 21775455

Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Ren Zhu1, Maryline Mancini-Bourgine, Xiao Ming Zhang, Florence Bayard, Qiang Deng, Marie-Louise Michel.   

Abstract

Plasmid DNA vaccines serve in a wide array of applications ranging from prophylactic vaccines to potential therapeutic tools against infectious diseases and cancer. In this study, we analyzed the mechanisms underlying the activation of natural killer (NK) cells and their potential role in adaptive immunity during DNA-based immunization against hepatitis B virus surface antigen in mice. We observed that the mature Mac-1(+) CD27(-) NK cell subset increased in the liver of mice early after DNA injection, whereas the number of the less mature Mac-1(+) CD27(+) NK cells in the liver and spleen was significantly reduced. This effect was attributed to bacterial sequences present in the plasmid backbone rather than to the encoded antigen and was not observed in immunized MyD88-deficient mice. The activation of NK cells by plasmid-DNA injection was associated with an increase in their effector functions that depended on the expressed antigen. Maturation of NK cells was abrogated in the absence of T cells, suggesting that cross talk exists between NK cells and antigen-specific T cells. Taken together, our data unravel the mechanics of plasmid vector-induced maturation of NK cells and plasmid-encoded antigen-dependent activation of NK cells required for a crucial role of NK cells in DNA vaccine-induced immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775455      PMCID: PMC3196460          DOI: 10.1128/JVI.00062-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo.

Authors:  Hideto Nishikado; Kaori Mukai; Yohei Kawano; Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 2.  NK cells at the interface between innate and adaptive immunity.

Authors:  A Moretta; E Marcenaro; S Parolini; G Ferlazzo; L Moretta
Journal:  Cell Death Differ       Date:  2007-06-01       Impact factor: 15.828

3.  CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Authors:  E Malanchère-Brès; P J Payette; M Mancini; P Tiollais; H L Davis; M L Michel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Authors:  Y Sato; M Roman; H Tighe; D Lee; M Corr; M D Nguyen; G J Silverman; M Lotz; D A Carson; E Raz
Journal:  Science       Date:  1996-07-19       Impact factor: 47.728

5.  Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: Correlation with T lymphocyte subsets, NK cells and liver inflammation.

Authors:  Ming-Xian Yan; Hai-Ting Mao; Qian Liu; Wen-Qi Wang; Yan-Qing Li
Journal:  Hepatol Res       Date:  2006-05-02       Impact factor: 4.288

6.  Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.

Authors:  M Mancini; M Hadchouel; P Tiollais; M L Michel
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

7.  Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen.

Authors:  Reinhold Schirmbeck; Waltraud Böhm; Nicolas Fissolo; Karl Melber; Jörg Reimann
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

8.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

9.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

10.  Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.

Authors:  Daniel Scott-Algara; Maryline Mancini-Bourgine; Hélène Fontaine; Stanislas Pol; Marie-Louise Michel
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more
  3 in total

1.  A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria.

Authors:  Frédéric Coutant; Raul Yusef Sanchez David; Tristan Félix; Aude Boulay; Laxmee Caleechurn; Philippe Souque; Catherine Thouvenot; Catherine Bourgouin; Anne-Sophie Beignon; Pierre Charneau
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

Review 2.  Cellular senescence as a potential mediator of COVID-19 severity in the elderly.

Authors:  Jamil Nehme; Michela Borghesan; Sebastian Mackedenski; Thomas G Bird; Marco Demaria
Journal:  Aging Cell       Date:  2020-09-21       Impact factor: 9.304

Review 3.  Natural killer cells in hepatitis B virus infection.

Authors:  Shao-fei Wu; Wen-jing Wang; Yue-qiu Gao
Journal:  Braz J Infect Dis       Date:  2015-06-25       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.